Cargando…

A Comparison of Free and Total 25-hydroxyvitamin D Levels as Functional Indicators of Bone Health in Healthy Children

Abstract Context: The “free hormone” hypothesis suggests that the free 25-hydroxyvitamin D (25OHD(Free)) level may usefully indicate bone health. Objective: To determine which vitamin D measure is optimally correlated with clinical and bone parameters in healthy children. Design and Participants: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heo, You Joung, Lee, Yun Jeong, Lee, Kyunghoon, Kim, Jae Hyun, Shin, Choong Ho, Lee, Young Ah, Song, Junghan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089995/ http://dx.doi.org/10.1210/jendso/bvab048.548

Ejemplares similares

Total, bioavailable and free 25-hydroxyvitamin D levels as functional indicators for bone parameters in healthy children
por: Heo, You Joung, et al.
Publicado: (2021)

SAT-514 The Decrease in Serum Parathyroid Hormone on Vitamin D Treatment Is Similar When Comparing Increases in Serum Free or Total 25 Hydroxyvitamin D in White and Black Women
por: Smith, Lynette, et al.
Publicado: (2019)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Oleanolic Acid Modulates 25-Hydroxyvitamin D(3) 1-alpha-hydroxylase in Osteoblasts and Human Mesenchymal Stem Cells
por: Yu, Wen-Xuan, et al.
Publicado: (2021)

Lack of Association Between 25-Hydroxyvitamin D Level and Outcomes in Hospitalized Indian Patients With COVID-19
por: Jevalikar, Ganesh, et al.
Publicado: (2021)

LBSAT229 Extended-release Calcifediol Effectively Raised 25-hydroxyvitamin D In CKD Despite Obesity
por: Strugnell, Stephen A, et al.
Publicado: (2022)

Total, Free and Bioavailble 25 OH D and Bone Disease in Primary Hyperparathyroidism
por: Santos, Lívia Marcela, et al.
Publicado: (2021)

ODP096 Hypercalcemia Secondary to Vitamin D Supplementation with Normal 25-Hydroxyvitamin D Level in an Elderly Female - Case Report
por: Arora, Gunjan, et al.
Publicado: (2022)

MON-388 Total and Free 1,25dihydroxyvitamin D Levels in Postmenopausal Patients with Primary Hyperparathyroidism
por: Meng, Lingqiong, et al.
Publicado: (2020)

LBODP016 Lithocholic Acid Induced 25-hydroxyvitamin D-1alpha Hydroxylase (cyp27b1) Expression And Activities In Vitro And In Vivo
por: Lam, Chung Yan, et al.
Publicado: (2022)

Therapeutic Potentials of Dimeric (Cys25)PTH(1–34) Peptide for Osteoporosis and Fracture Healing of the Bones- Buy One, Get One Free
por: Park, Doori, et al.
Publicado: (2021)

PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022)

Free, bioavailable 25-hydroxyvitamin D levels and their association with diabetic ketoacidosis in children with type 1 diabetes at diagnosis
por: Choe, Yunsoo, et al.
Publicado: (2022)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

SAT-356 Reversible Suppression of Serum 1,25-Dihydroxyvitamin D in Williams Syndrome
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

SAT246 Ectopic (Penile) Calcification in 1, 25 Vitamin D Induced Hypercalcemia
por: Berquist, John, et al.
Publicado: (2023)

1-25OH(2)D Mediated Hypercalcemia Secondary to DISR From Immune Checkpoint Inhibitors
por: Disanti, Domenic, et al.
Publicado: (2021)

Appropriate Cutoff for 25OHD Levels in the Diagnosis of Normocalcemic Primary Hyperparathyroidism (NPHPT): A Systematic Review
por: Yedla, Niharika, et al.
Publicado: (2021)

LBSAT131 Extended-release Calcifediol Reduced Ipth And Normalized 1,25-dihydroxyvitamin D In Esrd.
por: Ashfaq, Akhtar, et al.
Publicado: (2022)

SAT240 Recurrent Hypercalcemia Due To 1,25 Dihydroxy Vitamin D Elevation Of Unclear Etiology
por: Javvaji, Abhiram, et al.
Publicado: (2023)

SAT-531 Low 25-OH-Vitamin D Levels in Women Observed before Initiating Osteoporosis Therapy
por: Li, Christina, et al.
Publicado: (2019)

ODP079 BCG-Osis, a Rare Cause of 1,25 Hydroxy Vitamin D Mediated Hypercalcemia
por: Azim, Sidra, et al.
Publicado: (2022)

SUN-393 The Impact of Micronutrients on Cellular Metabolism and Healthy Aging
por: Astrup, Arne, et al.
Publicado: (2020)

ODP109 PARATHYROID HORMONE AND 25 OH VITAMINA D IN PREGNANCY: DATA FROM AN ARGENTINEAN COHORT SUPPORTING SUPPLEMENTATION.
por: Torres, Marta Isabel, et al.
Publicado: (2022)

Type 2 Diabetes Clusters Indicate Diabetes Duration Key in Fracture Risk
por: Ghatan, Sam, et al.
Publicado: (2021)

Sarcopenic Obesity Indices Are Major Determinants of Bone Strength in Older Adults With Obesity
por: Gregori, Giulia, et al.
Publicado: (2021)

ODP102 Indicators for the effects of calcimimetics on hypercalcemia in the elderly patients with primary hyperparathyroidism.
por: Yamamoto, Koichro, et al.
Publicado: (2022)

SAT-490 Severe Hypercalcemia after Revision of Septic Left Total Knee
por: Zozobrado, Kaye, et al.
Publicado: (2019)

SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023)

THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
por: Yazdi, Zhinoosossadat Shahidzadeh, et al.
Publicado: (2023)

In Vitro Effect of CCL11 on Myogenic Differentiation and Its Relevance With Sarcopenia Parameters in Older Adults
por: Park, So Jeong, et al.
Publicado: (2021)

Circulating Lipocalin-2 Predicts Changes in Lumbar Spine Bone Mineral Density After Parathyroidectomy in Primary Hyperparathyroidism
por: Lee, Seunghyun, et al.
Publicado: (2021)

Circulating MicroRNA-23a-5p Is a Potential Biomarker for Recovery of Bone Mass After Parathyroidectomy in Primary Hyperparathyroidism
por: Lee, Seunghyun, et al.
Publicado: (2021)

SAT-530 Establishment of a Glucocorticoid (GC) Regimen to Induce Both Growth Retardation and Osteoporosis in C57BL/10 Muscular Dystrophy Mouse Models
por: Wood, Claire, et al.
Publicado: (2019)

SAT176 Comparison Of Prevalence For Normocalcemic Primary Hyperparathyroidism (NPHPT) Using Different 25(OH)D Levels: A Systematic Review
por: Farooqi, Iqra N, et al.
Publicado: (2023)

ODP129 Variation in 25(OH)D Levels, Measurement Methods and Prevalence of Vitamin D Deficiency: a Systematic Review and Meta-analysis
por: Premaor, Melissa, et al.
Publicado: (2022)

Machine Learning-Derived Simple Score Predicts the Risk of Tertiary Hyperparathyroidism Requiring Surgical Treatment Among Kidney Transplant Recipients: The DPC score
por: Hong, Namki, et al.
Publicado: (2021)

ODP111 PERSISTENT TERTIARY HYPERPARATHYROIDISM AFTER TOTAL PARATHYROIDECTOMY AND KIDNEY TRANSPLANTATION: THE CASE OF THE SUPERNUMERARY GLANDS
por: Grigorie, Daniel, et al.
Publicado: (2022)

MON-491 Persistent Isolated Hypophosphatemia after Intravenous Ferric Carboxymaltose Infusion in a Patient with Total Gastrectomy
por: Bailey, Rosemary, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_709vg0sekpl9b8oruhmk0pq9di